nodes	percent_of_prediction	percent_of_DWPC	metapath
Valrubicin—Daunorubicin—hematologic cancer	0.158	0.412	CrCtD
Valrubicin—TOP2A—hematologic cancer	0.137	1	CbGaD
Valrubicin—Idarubicin—hematologic cancer	0.12	0.312	CrCtD
Valrubicin—Epirubicin—hematologic cancer	0.055	0.143	CrCtD
Valrubicin—Doxorubicin—hematologic cancer	0.0509	0.133	CrCtD
Valrubicin—TOP2A—Idarubicin—hematologic cancer	0.0494	0.281	CbGbCtD
Valrubicin—TOP2A—Daunorubicin—hematologic cancer	0.035	0.199	CbGbCtD
Valrubicin—Epirubicin—Daunorubicin—hematologic cancer	0.034	0.137	CrCrCtD
Valrubicin—Idarubicin—Daunorubicin—hematologic cancer	0.034	0.137	CrCrCtD
Valrubicin—Doxorubicin—Daunorubicin—hematologic cancer	0.034	0.137	CrCrCtD
Valrubicin—TOP2A—Teniposide—hematologic cancer	0.0304	0.173	CbGbCtD
Valrubicin—Daunorubicin—Idarubicin—hematologic cancer	0.0258	0.104	CrCrCtD
Valrubicin—Doxorubicin—Idarubicin—hematologic cancer	0.0258	0.104	CrCrCtD
Valrubicin—Epirubicin—Idarubicin—hematologic cancer	0.0258	0.104	CrCrCtD
Valrubicin—TOP2A—Mitoxantrone—hematologic cancer	0.0213	0.121	CbGbCtD
Valrubicin—TOP2A—Epirubicin—hematologic cancer	0.0172	0.0978	CbGbCtD
Valrubicin—TOP2A—Etoposide—hematologic cancer	0.0134	0.0762	CbGbCtD
Valrubicin—Idarubicin—Epirubicin—hematologic cancer	0.0118	0.0478	CrCrCtD
Valrubicin—Doxorubicin—Epirubicin—hematologic cancer	0.0118	0.0478	CrCrCtD
Valrubicin—Daunorubicin—Epirubicin—hematologic cancer	0.0118	0.0478	CrCrCtD
Valrubicin—Idarubicin—Doxorubicin—hematologic cancer	0.011	0.0442	CrCrCtD
Valrubicin—Daunorubicin—Doxorubicin—hematologic cancer	0.011	0.0442	CrCrCtD
Valrubicin—Epirubicin—Doxorubicin—hematologic cancer	0.011	0.0442	CrCrCtD
Valrubicin—TOP2A—Doxorubicin—hematologic cancer	0.00914	0.052	CbGbCtD
Valrubicin—Daunorubicin—TOP2B—hematologic cancer	0.000517	0.358	CrCbGaD
Valrubicin—TOP2A—G0 and Early G1—MYBL2—hematologic cancer	0.000395	0.049	CbGpPWpGaD
Valrubicin—TOP2A—Gastric Cancer Network 1—MYBL2—hematologic cancer	0.000351	0.0435	CbGpPWpGaD
Valrubicin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—RUNX1—hematologic cancer	0.000239	0.0296	CbGpPWpGaD
Valrubicin—TOP2A—Retinoblastoma (RB) in Cancer—DCK—hematologic cancer	0.000222	0.0275	CbGpPWpGaD
Valrubicin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—CEBPD—hematologic cancer	0.000222	0.0275	CbGpPWpGaD
Valrubicin—TOP2A—Gastric Cancer Network 1—H3F3A—hematologic cancer	0.0002	0.0248	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—PPP1R13L—hematologic cancer	0.000195	0.0242	CbGpPWpGaD
Valrubicin—Idarubicin—TOP2A—hematologic cancer	0.000189	0.131	CrCbGaD
Valrubicin—TOP2A—Retinoblastoma (RB) in Cancer—SMC3—hematologic cancer	0.000152	0.0189	CbGpPWpGaD
Valrubicin—Epirubicin—TOP2A—hematologic cancer	0.000143	0.0992	CrCbGaD
Valrubicin—TOP2A—Circadian rythm related genes—PER3—hematologic cancer	0.000142	0.0176	CbGpPWpGaD
Valrubicin—TOP2A—G0 and Early G1—CDK2—hematologic cancer	0.000129	0.016	CbGpPWpGaD
Valrubicin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—FBXW7—hematologic cancer	0.000125	0.0155	CbGpPWpGaD
Valrubicin—TOP2A—Circadian rythm related genes—CRY2—hematologic cancer	0.000121	0.015	CbGpPWpGaD
Valrubicin—TOP2A—Circadian rythm related genes—CRY1—hematologic cancer	0.000121	0.015	CbGpPWpGaD
Valrubicin—TOP2A—Circadian rythm related genes—PER2—hematologic cancer	0.000121	0.015	CbGpPWpGaD
Valrubicin—Doxorubicin—NQO1—hematologic cancer	0.000118	0.0815	CrCbGaD
Valrubicin—Doxorubicin—ABCC3—hematologic cancer	0.000116	0.0802	CrCbGaD
Valrubicin—TOP2A—Retinoblastoma (RB) in Cancer—CCND3—hematologic cancer	0.000104	0.013	CbGpPWpGaD
Valrubicin—TOP2A—Gastric Cancer Network 1—NOTCH1—hematologic cancer	0.000104	0.0129	CbGpPWpGaD
Valrubicin—TOP2A—Nilotinib—Imatinib—hematologic cancer	0.000103	0.0777	CbGdCrCtD
Valrubicin—TOP2A—Circadian rythm related genes—ID3—hematologic cancer	0.000103	0.0127	CbGpPWpGaD
Valrubicin—TOP2A—Mitotic G1-G1/S phases—MYBL2—hematologic cancer	0.000103	0.0127	CbGpPWpGaD
Valrubicin—Daunorubicin—TOP2A—hematologic cancer	0.000101	0.0702	CrCbGaD
Valrubicin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—HES1—hematologic cancer	9.37e-05	0.0116	CbGpPWpGaD
Valrubicin—TOP2A—Circadian rythm related genes—PER1—hematologic cancer	9.15e-05	0.0113	CbGpPWpGaD
Valrubicin—TOP2A—Circadian rythm related genes—KMT2A—hematologic cancer	9.15e-05	0.0113	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TOP1—hematologic cancer	8.72e-05	0.0108	CbGpPWpGaD
Valrubicin—TOP2A—Retinoblastoma (RB) in Cancer—SMC1A—hematologic cancer	8.46e-05	0.0105	CbGpPWpGaD
Valrubicin—TOP2A—Circadian rythm related genes—TOP1—hematologic cancer	8.37e-05	0.0104	CbGpPWpGaD
Valrubicin—Doxorubicin—TOP2A—hematologic cancer	8.23e-05	0.057	CrCbGaD
Valrubicin—TOP2A—Circadian rythm related genes—ID2—hematologic cancer	8.16e-05	0.0101	CbGpPWpGaD
Valrubicin—TOP2A—Retinoblastoma (RB) in Cancer—CDK6—hematologic cancer	7.79e-05	0.00965	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—RARA—hematologic cancer	7.77e-05	0.00964	CbGpPWpGaD
Valrubicin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—ATM—hematologic cancer	7.38e-05	0.00915	CbGpPWpGaD
Valrubicin—TOP2A—Mitotic G1-G1/S phases—CCND3—hematologic cancer	7.35e-05	0.00911	CbGpPWpGaD
Valrubicin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—NOTCH1—hematologic cancer	7.07e-05	0.00877	CbGpPWpGaD
Valrubicin—Daunorubicin—ABCG2—hematologic cancer	6.92e-05	0.048	CrCbGaD
Valrubicin—TOP2A—Circadian rythm related genes—ARNTL—hematologic cancer	6.52e-05	0.00808	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—BBC3—hematologic cancer	6.44e-05	0.00798	CbGpPWpGaD
Valrubicin—TOP2A—Retinoblastoma (RB) in Cancer—ABL1—hematologic cancer	6.05e-05	0.00751	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—JUND—hematologic cancer	5.78e-05	0.00716	CbGpPWpGaD
Valrubicin—TOP2A—Topotecan—Irinotecan—hematologic cancer	5.7e-05	0.0431	CbGdCrCtD
Valrubicin—TOP2A—Etoposide—Teniposide—hematologic cancer	5.66e-05	0.0429	CbGdCrCtD
Valrubicin—Doxorubicin—ABCG2—hematologic cancer	5.62e-05	0.0389	CrCbGaD
Valrubicin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—hematologic cancer	5.62e-05	0.00696	CbGpPWpGaD
Valrubicin—TOP2A—Circadian rythm related genes—JUND—hematologic cancer	5.55e-05	0.00687	CbGpPWpGaD
Valrubicin—TOP2A—Mitotic G1-G1/S phases—CDK6—hematologic cancer	5.48e-05	0.00679	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—WT1—hematologic cancer	5.48e-05	0.00679	CbGpPWpGaD
Valrubicin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—MDM2—hematologic cancer	5.45e-05	0.00675	CbGpPWpGaD
Valrubicin—TOP2A—Gastric Cancer Network 2—MYC—hematologic cancer	5.31e-05	0.00658	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CST3—hematologic cancer	5.19e-05	0.00643	CbGpPWpGaD
Valrubicin—TOP2A—Vindesine—Vinorelbine—hematologic cancer	5.1e-05	0.0386	CbGdCrCtD
Valrubicin—TOP2A—Circadian rythm related genes—CST3—hematologic cancer	4.98e-05	0.00617	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—PML—hematologic cancer	4.88e-05	0.00605	CbGpPWpGaD
Valrubicin—TOP2A—Retinoblastoma (RB) in Cancer—CDK2—hematologic cancer	4.75e-05	0.00589	CbGpPWpGaD
Valrubicin—TOP2A—Mitotic G1-G1/S phases—CCND2—hematologic cancer	4.71e-05	0.00584	CbGpPWpGaD
Valrubicin—TOP2A—Circadian rythm related genes—PML—hematologic cancer	4.69e-05	0.00581	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle—RAD1—hematologic cancer	4.63e-05	0.00574	CbGpPWpGaD
Valrubicin—TOP2A—Retinoblastoma (RB) in Cancer—CDK4—hematologic cancer	4.49e-05	0.00557	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP7—hematologic cancer	4.44e-05	0.00551	CbGpPWpGaD
Valrubicin—TOP2A—Gastric Cancer Network 2—TP53—hematologic cancer	4.36e-05	0.00541	CbGpPWpGaD
Valrubicin—TOP2A—Podofilox—Teniposide—hematologic cancer	4.32e-05	0.0327	CbGdCrCtD
Valrubicin—TOP2A—Cell Cycle—TERF2—hematologic cancer	4.27e-05	0.0053	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—EZH2—hematologic cancer	4.24e-05	0.00526	CbGpPWpGaD
Valrubicin—TOP2A—Mitotic G1-G1/S phases—CDKN2B—hematologic cancer	4.22e-05	0.00523	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle, Mitotic—RAD21—hematologic cancer	4.22e-05	0.00523	CbGpPWpGaD
Valrubicin—TOP2A—Vindesine—Vinblastine—hematologic cancer	4.07e-05	0.0308	CbGdCrCtD
Valrubicin—TOP2A—Vindesine—Vincristine—hematologic cancer	4.07e-05	0.0308	CbGdCrCtD
Valrubicin—TOP2A—Circadian rythm related genes—EZH2—hematologic cancer	4.07e-05	0.00505	CbGpPWpGaD
Valrubicin—TOP2A—Floxuridine—Pentostatin—hematologic cancer	3.93e-05	0.0297	CbGdCrCtD
Valrubicin—TOP2A—Cell Cycle, Mitotic—SMC3—hematologic cancer	3.92e-05	0.00487	CbGpPWpGaD
Valrubicin—TOP2A—Retinoblastoma (RB) in Cancer—RB1—hematologic cancer	3.9e-05	0.00484	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—IL3—hematologic cancer	3.86e-05	0.00479	CbGpPWpGaD
Valrubicin—TOP2A—Epirubicin—Daunorubicin—hematologic cancer	3.85e-05	0.0291	CbGdCrCtD
Valrubicin—TOP2A—Idarubicin—Daunorubicin—hematologic cancer	3.85e-05	0.0291	CbGdCrCtD
Valrubicin—TOP2A—Doxorubicin—Daunorubicin—hematologic cancer	3.85e-05	0.0291	CbGdCrCtD
Valrubicin—TOP2A—Circadian rythm related genes—HDAC2—hematologic cancer	3.84e-05	0.00477	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle—RAD21—hematologic cancer	3.77e-05	0.00468	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle, Mitotic—MYBL2—hematologic cancer	3.76e-05	0.00466	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—STAT1—hematologic cancer	3.59e-05	0.00445	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle—SMC3—hematologic cancer	3.51e-05	0.00435	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—AR—hematologic cancer	3.47e-05	0.0043	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle—POT1—hematologic cancer	3.36e-05	0.00417	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle—MYBL2—hematologic cancer	3.36e-05	0.00417	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—GRB2—hematologic cancer	3.36e-05	0.00416	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—PDGFA—hematologic cancer	3.35e-05	0.00415	CbGpPWpGaD
Valrubicin—TOP2A—Mitotic G1-G1/S phases—CDK2—hematologic cancer	3.34e-05	0.00414	CbGpPWpGaD
Valrubicin—TOP2A—Retinoblastoma (RB) in Cancer—MDM2—hematologic cancer	3.33e-05	0.00413	CbGpPWpGaD
Valrubicin—TOP2A—Menadione—Thalidomide—hematologic cancer	3.27e-05	0.0248	CbGdCrCtD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—ABL1—hematologic cancer	3.23e-05	0.004	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—STAT5A—hematologic cancer	3.23e-05	0.004	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN2B—hematologic cancer	3.2e-05	0.00397	CbGpPWpGaD
Valrubicin—TOP2A—Mitotic G1-G1/S phases—CDK4—hematologic cancer	3.16e-05	0.00392	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle—ATR—hematologic cancer	3.13e-05	0.00388	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—ABCB1—hematologic cancer	3.13e-05	0.00387	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle, Mitotic—STAG2—hematologic cancer	3.12e-05	0.00386	CbGpPWpGaD
Valrubicin—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1B—hematologic cancer	3.04e-05	0.00377	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—FGF1—hematologic cancer	3e-05	0.00372	CbGpPWpGaD
Valrubicin—TOP2A—Cladribine—Pentostatin—hematologic cancer	2.97e-05	0.0225	CbGdCrCtD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—BAX—hematologic cancer	2.96e-05	0.00367	CbGpPWpGaD
Valrubicin—TOP2A—Daunorubicin—Idarubicin—hematologic cancer	2.92e-05	0.0221	CbGdCrCtD
Valrubicin—TOP2A—Doxorubicin—Idarubicin—hematologic cancer	2.92e-05	0.0221	CbGdCrCtD
Valrubicin—TOP2A—Epirubicin—Idarubicin—hematologic cancer	2.92e-05	0.0221	CbGdCrCtD
Valrubicin—TOP2A—Circadian rythm related genes—NCOR1—hematologic cancer	2.91e-05	0.00361	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—PDGFRA—hematologic cancer	2.91e-05	0.0036	CbGpPWpGaD
Valrubicin—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—hematologic cancer	2.9e-05	0.00359	CbGpPWpGaD
Valrubicin—Daunorubicin—ABCB1—hematologic cancer	2.88e-05	0.02	CrCbGaD
Valrubicin—TOP2A—Cell Cycle, Mitotic—FOXM1—hematologic cancer	2.85e-05	0.00353	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle, Mitotic—H3F3B—hematologic cancer	2.85e-05	0.00353	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—FASLG—hematologic cancer	2.82e-05	0.0035	CbGpPWpGaD
Valrubicin—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1A—hematologic cancer	2.81e-05	0.00348	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle—STAG2—hematologic cancer	2.79e-05	0.00346	CbGpPWpGaD
Valrubicin—TOP2A—Circadian rythm related genes—PRKCG—hematologic cancer	2.78e-05	0.00345	CbGpPWpGaD
Valrubicin—TOP2A—Vincristine—Vinorelbine—hematologic cancer	2.75e-05	0.0208	CbGdCrCtD
Valrubicin—TOP2A—Mitotic G1-G1/S phases—RB1—hematologic cancer	2.75e-05	0.00341	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—FAS—hematologic cancer	2.72e-05	0.00337	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle, Mitotic—CCND3—hematologic cancer	2.7e-05	0.00334	CbGpPWpGaD
Valrubicin—TOP2A—Cladribine—Clofarabine—hematologic cancer	2.65e-05	0.0201	CbGdCrCtD
Valrubicin—TOP2A—Circadian rythm related genes—FAS—hematologic cancer	2.61e-05	0.00324	CbGpPWpGaD
Valrubicin—TOP2A—Vinorelbine—Vincristine—hematologic cancer	2.57e-05	0.0195	CbGdCrCtD
Valrubicin—TOP2A—Vinorelbine—Vinblastine—hematologic cancer	2.57e-05	0.0195	CbGdCrCtD
Valrubicin—TOP2A—Podofilox—Etoposide—hematologic cancer	2.57e-05	0.0194	CbGdCrCtD
Valrubicin—TOP2A—Teniposide—Etoposide—hematologic cancer	2.57e-05	0.0194	CbGdCrCtD
Valrubicin—TOP2A—Cell Cycle, Mitotic—NUP98—hematologic cancer	2.57e-05	0.00318	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle—FOXM1—hematologic cancer	2.55e-05	0.00316	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle—H3F3B—hematologic cancer	2.55e-05	0.00316	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CDK2—hematologic cancer	2.53e-05	0.00314	CbGpPWpGaD
Valrubicin—TOP2A—Cladribine—Nelarabine—hematologic cancer	2.49e-05	0.0189	CbGdCrCtD
Valrubicin—TOP2A—Cell Cycle, Mitotic—NUP214—hematologic cancer	2.47e-05	0.00307	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle—NPM1—hematologic cancer	2.45e-05	0.00304	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK14—hematologic cancer	2.43e-05	0.00301	CbGpPWpGaD
Valrubicin—TOP2A—Mitotic G1-G1/S phases—CDKN2A—hematologic cancer	2.41e-05	0.00299	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle—CCND3—hematologic cancer	2.41e-05	0.00299	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—ATM—hematologic cancer	2.4e-05	0.00298	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CDK4—hematologic cancer	2.39e-05	0.00297	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—ESR1—hematologic cancer	2.38e-05	0.00295	CbGpPWpGaD
Valrubicin—TOP2A—Floxuridine—Cladribine—hematologic cancer	2.36e-05	0.0179	CbGdCrCtD
Valrubicin—Doxorubicin—ABCB1—hematologic cancer	2.34e-05	0.0162	CrCbGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—BAD—hematologic cancer	2.33e-05	0.00288	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—NFKBIA—hematologic cancer	2.33e-05	0.00288	CbGpPWpGaD
Valrubicin—TOP2A—Retinoblastoma (RB) in Cancer—MYC—hematologic cancer	2.33e-05	0.00288	CbGpPWpGaD
Valrubicin—TOP2A—Clofarabine—Nelarabine—hematologic cancer	2.3e-05	0.0174	CbGdCrCtD
Valrubicin—TOP2A—Circadian rythm related genes—CDK4—hematologic cancer	2.3e-05	0.00285	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle—NUP98—hematologic cancer	2.3e-05	0.00285	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle—NUP214—hematologic cancer	2.21e-05	0.00274	CbGpPWpGaD
Valrubicin—TOP2A—Vinblastine—Vinorelbine—hematologic cancer	2.21e-05	0.0167	CbGdCrCtD
Valrubicin—TOP2A—Vincristine—Vinblastine—hematologic cancer	2.2e-05	0.0166	CbGdCrCtD
Valrubicin—TOP2A—Cell Cycle, Mitotic—SMC1A—hematologic cancer	2.18e-05	0.00271	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CREB1—hematologic cancer	2.14e-05	0.00266	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle, Mitotic—H3F3A—hematologic cancer	2.14e-05	0.00265	CbGpPWpGaD
Valrubicin—TOP2A—Mitotic G1-G1/S phases—CDKN1B—hematologic cancer	2.14e-05	0.00265	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP8—hematologic cancer	2.1e-05	0.0026	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CREBBP—hematologic cancer	2.09e-05	0.00259	CbGpPWpGaD
Valrubicin—TOP2A—Cytarabine—Clofarabine—hematologic cancer	2.08e-05	0.0158	CbGdCrCtD
Valrubicin—TOP2A—Circadian rythm related genes—CREB1—hematologic cancer	2.06e-05	0.00255	CbGpPWpGaD
Valrubicin—TOP2A—Mitotic G1-G1/S phases—CCND1—hematologic cancer	2.04e-05	0.00253	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle—MLH1—hematologic cancer	2.04e-05	0.00253	CbGpPWpGaD
Valrubicin—Rash—Bleomycin—hematologic cancer	2.03e-05	0.000456	CcSEcCtD
Valrubicin—Dermatitis—Bleomycin—hematologic cancer	2.03e-05	0.000456	CcSEcCtD
Valrubicin—Asthenia—Carmustine—hematologic cancer	2.02e-05	0.000453	CcSEcCtD
Valrubicin—Vomiting—Vinorelbine—hematologic cancer	2.02e-05	0.000452	CcSEcCtD
Valrubicin—Body temperature increased—Gemcitabine—hematologic cancer	2.01e-05	0.000452	CcSEcCtD
Valrubicin—TOP2A—Cell Cycle, Mitotic—CDK6—hematologic cancer	2.01e-05	0.00249	CbGpPWpGaD
Valrubicin—Dysuria—Epirubicin—hematologic cancer	2.01e-05	0.00045	CcSEcCtD
Valrubicin—Diarrhoea—Thalidomide—hematologic cancer	2.01e-05	0.00045	CcSEcCtD
Valrubicin—Dizziness—Thiotepa—hematologic cancer	2e-05	0.000449	CcSEcCtD
Valrubicin—Asthenia—Alitretinoin—hematologic cancer	2e-05	0.000449	CcSEcCtD
Valrubicin—Rash—Vinorelbine—hematologic cancer	2e-05	0.000449	CcSEcCtD
Valrubicin—Dermatitis—Vinorelbine—hematologic cancer	2e-05	0.000448	CcSEcCtD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—MAP2K1—hematologic cancer	1.99e-05	0.00247	CbGpPWpGaD
Valrubicin—Headache—Vinorelbine—hematologic cancer	1.99e-05	0.000446	CcSEcCtD
Valrubicin—Pollakiuria—Epirubicin—hematologic cancer	1.98e-05	0.000444	CcSEcCtD
Valrubicin—Malaise—Betamethasone—hematologic cancer	1.98e-05	0.000444	CcSEcCtD
Valrubicin—Malaise—Dexamethasone—hematologic cancer	1.98e-05	0.000444	CcSEcCtD
Valrubicin—Asthenia—Ifosfamide—hematologic cancer	1.98e-05	0.000443	CcSEcCtD
Valrubicin—TOP2A—Mitotic G1-G1/S phases—CDKN1A—hematologic cancer	1.97e-05	0.00245	CbGpPWpGaD
Valrubicin—Pruritus—Alitretinoin—hematologic cancer	1.97e-05	0.000442	CcSEcCtD
Valrubicin—TOP2A—Cytarabine—Nelarabine—hematologic cancer	1.96e-05	0.0148	CbGdCrCtD
Valrubicin—Feeling abnormal—Cisplatin—hematologic cancer	1.96e-05	0.000439	CcSEcCtD
Valrubicin—TOP2A—Cell Cycle—SMC1A—hematologic cancer	1.95e-05	0.00242	CbGpPWpGaD
Valrubicin—Pruritus—Ifosfamide—hematologic cancer	1.95e-05	0.000437	CcSEcCtD
Valrubicin—Haematuria—Methotrexate—hematologic cancer	1.95e-05	0.000437	CcSEcCtD
Valrubicin—TOP2A—Cladribine—Fludarabine—hematologic cancer	1.94e-05	0.0147	CbGdCrCtD
Valrubicin—Dizziness—Thalidomide—hematologic cancer	1.94e-05	0.000435	CcSEcCtD
Valrubicin—Hyperglycaemia—Epirubicin—hematologic cancer	1.94e-05	0.000434	CcSEcCtD
Valrubicin—Nausea—Bortezomib—hematologic cancer	1.93e-05	0.000433	CcSEcCtD
Valrubicin—Asthenia—Vincristine—hematologic cancer	1.93e-05	0.000432	CcSEcCtD
Valrubicin—Vomiting—Thiotepa—hematologic cancer	1.93e-05	0.000432	CcSEcCtD
Valrubicin—Diarrhoea—Carmustine—hematologic cancer	1.93e-05	0.000432	CcSEcCtD
Valrubicin—Pneumonia—Epirubicin—hematologic cancer	1.92e-05	0.000432	CcSEcCtD
Valrubicin—Nausea—Bleomycin—hematologic cancer	1.92e-05	0.00043	CcSEcCtD
Valrubicin—TOP2A—Cell Cycle—H3F3A—hematologic cancer	1.91e-05	0.00237	CbGpPWpGaD
Valrubicin—Rash—Thiotepa—hematologic cancer	1.91e-05	0.000428	CcSEcCtD
Valrubicin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—hematologic cancer	1.91e-05	0.00237	CbGpPWpGaD
Valrubicin—Dermatitis—Thiotepa—hematologic cancer	1.91e-05	0.000428	CcSEcCtD
Valrubicin—Diarrhoea—Alitretinoin—hematologic cancer	1.91e-05	0.000428	CcSEcCtD
Valrubicin—Headache—Thiotepa—hematologic cancer	1.9e-05	0.000426	CcSEcCtD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—FGF2—hematologic cancer	1.9e-05	0.00235	CbGpPWpGaD
Valrubicin—Diarrhoea—Ifosfamide—hematologic cancer	1.89e-05	0.000423	CcSEcCtD
Valrubicin—Nausea—Vinorelbine—hematologic cancer	1.88e-05	0.000423	CcSEcCtD
Valrubicin—Body temperature increased—Cisplatin—hematologic cancer	1.88e-05	0.000421	CcSEcCtD
Valrubicin—Asthenia—Irinotecan—hematologic cancer	1.88e-05	0.000421	CcSEcCtD
Valrubicin—Asthenia—Mitoxantrone—hematologic cancer	1.88e-05	0.000421	CcSEcCtD
Valrubicin—Myalgia—Dexamethasone—hematologic cancer	1.87e-05	0.000419	CcSEcCtD
Valrubicin—Myalgia—Betamethasone—hematologic cancer	1.87e-05	0.000419	CcSEcCtD
Valrubicin—Vomiting—Thalidomide—hematologic cancer	1.86e-05	0.000418	CcSEcCtD
Valrubicin—Dizziness—Carmustine—hematologic cancer	1.86e-05	0.000417	CcSEcCtD
Valrubicin—Urinary tract infection—Epirubicin—hematologic cancer	1.86e-05	0.000417	CcSEcCtD
Valrubicin—Dysuria—Doxorubicin—hematologic cancer	1.86e-05	0.000416	CcSEcCtD
Valrubicin—Rash—Thalidomide—hematologic cancer	1.85e-05	0.000414	CcSEcCtD
Valrubicin—Discomfort—Betamethasone—hematologic cancer	1.85e-05	0.000414	CcSEcCtD
Valrubicin—Discomfort—Dexamethasone—hematologic cancer	1.85e-05	0.000414	CcSEcCtD
Valrubicin—Dermatitis—Thalidomide—hematologic cancer	1.85e-05	0.000414	CcSEcCtD
Valrubicin—Dizziness—Alitretinoin—hematologic cancer	1.84e-05	0.000414	CcSEcCtD
Valrubicin—Diarrhoea—Vincristine—hematologic cancer	1.84e-05	0.000412	CcSEcCtD
Valrubicin—Headache—Thalidomide—hematologic cancer	1.84e-05	0.000412	CcSEcCtD
Valrubicin—Pollakiuria—Doxorubicin—hematologic cancer	1.83e-05	0.000411	CcSEcCtD
Valrubicin—Asthenia—Gemcitabine—hematologic cancer	1.83e-05	0.00041	CcSEcCtD
Valrubicin—Haematuria—Epirubicin—hematologic cancer	1.82e-05	0.000409	CcSEcCtD
Valrubicin—Dizziness—Ifosfamide—hematologic cancer	1.82e-05	0.000409	CcSEcCtD
Valrubicin—Pruritus—Gemcitabine—hematologic cancer	1.8e-05	0.000404	CcSEcCtD
Valrubicin—TOP2A—Cell Cycle, Mitotic—HSP90AA1—hematologic cancer	1.8e-05	0.00223	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—BCL2—hematologic cancer	1.8e-05	0.00223	CbGpPWpGaD
Valrubicin—Nausea—Thiotepa—hematologic cancer	1.8e-05	0.000404	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Triamcinolone—hematologic cancer	1.8e-05	0.000403	CcSEcCtD
Valrubicin—TOP2A—Clofarabine—Fludarabine—hematologic cancer	1.8e-05	0.0136	CbGdCrCtD
Valrubicin—TOP2A—Cell Cycle—CDK6—hematologic cancer	1.8e-05	0.00223	CbGpPWpGaD
Valrubicin—Feeling abnormal—Etoposide—hematologic cancer	1.79e-05	0.000402	CcSEcCtD
Valrubicin—Hyperglycaemia—Doxorubicin—hematologic cancer	1.79e-05	0.000402	CcSEcCtD
Valrubicin—Diarrhoea—Mitoxantrone—hematologic cancer	1.79e-05	0.000402	CcSEcCtD
Valrubicin—Diarrhoea—Irinotecan—hematologic cancer	1.79e-05	0.000402	CcSEcCtD
Valrubicin—Vomiting—Carmustine—hematologic cancer	1.79e-05	0.000401	CcSEcCtD
Valrubicin—Pneumonia—Doxorubicin—hematologic cancer	1.78e-05	0.000399	CcSEcCtD
Valrubicin—Gastrointestinal pain—Etoposide—hematologic cancer	1.78e-05	0.000399	CcSEcCtD
Valrubicin—Dizziness—Vincristine—hematologic cancer	1.78e-05	0.000398	CcSEcCtD
Valrubicin—Rash—Carmustine—hematologic cancer	1.77e-05	0.000398	CcSEcCtD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—MDM2—hematologic cancer	1.77e-05	0.0022	CbGpPWpGaD
Valrubicin—Ill-defined disorder—Prednisone—hematologic cancer	1.77e-05	0.000398	CcSEcCtD
Valrubicin—Dermatitis—Carmustine—hematologic cancer	1.77e-05	0.000398	CcSEcCtD
Valrubicin—Vomiting—Alitretinoin—hematologic cancer	1.77e-05	0.000398	CcSEcCtD
Valrubicin—Feeling abnormal—Prednisolone—hematologic cancer	1.77e-05	0.000397	CcSEcCtD
Valrubicin—TOP2A—Vinblastine—Vincristine—hematologic cancer	1.77e-05	0.0134	CbGdCrCtD
Valrubicin—Anaemia—Prednisone—hematologic cancer	1.77e-05	0.000396	CcSEcCtD
Valrubicin—Headache—Carmustine—hematologic cancer	1.76e-05	0.000395	CcSEcCtD
Valrubicin—Rash—Alitretinoin—hematologic cancer	1.76e-05	0.000394	CcSEcCtD
Valrubicin—Dermatitis—Alitretinoin—hematologic cancer	1.76e-05	0.000394	CcSEcCtD
Valrubicin—Vomiting—Ifosfamide—hematologic cancer	1.75e-05	0.000393	CcSEcCtD
Valrubicin—Headache—Alitretinoin—hematologic cancer	1.75e-05	0.000392	CcSEcCtD
Valrubicin—Diarrhoea—Gemcitabine—hematologic cancer	1.74e-05	0.000391	CcSEcCtD
Valrubicin—Nausea—Thalidomide—hematologic cancer	1.74e-05	0.00039	CcSEcCtD
Valrubicin—Rash—Ifosfamide—hematologic cancer	1.74e-05	0.00039	CcSEcCtD
Valrubicin—Dermatitis—Ifosfamide—hematologic cancer	1.74e-05	0.000389	CcSEcCtD
Valrubicin—Dizziness—Irinotecan—hematologic cancer	1.73e-05	0.000388	CcSEcCtD
Valrubicin—TOP2A—Cell Cycle, Mitotic—CCND2—hematologic cancer	1.73e-05	0.00214	CbGpPWpGaD
Valrubicin—Malaise—Prednisone—hematologic cancer	1.72e-05	0.000387	CcSEcCtD
Valrubicin—Body temperature increased—Etoposide—hematologic cancer	1.72e-05	0.000386	CcSEcCtD
Valrubicin—Abdominal pain—Etoposide—hematologic cancer	1.72e-05	0.000386	CcSEcCtD
Valrubicin—Urinary tract infection—Doxorubicin—hematologic cancer	1.72e-05	0.000386	CcSEcCtD
Valrubicin—Vomiting—Vincristine—hematologic cancer	1.71e-05	0.000383	CcSEcCtD
Valrubicin—Asthenia—Cisplatin—hematologic cancer	1.7e-05	0.000382	CcSEcCtD
Valrubicin—TOP2A—Clofarabine—Cytarabine—hematologic cancer	1.7e-05	0.0129	CbGdCrCtD
Valrubicin—Rash—Vincristine—hematologic cancer	1.69e-05	0.00038	CcSEcCtD
Valrubicin—Dermatitis—Vincristine—hematologic cancer	1.69e-05	0.00038	CcSEcCtD
Valrubicin—Oedema peripheral—Epirubicin—hematologic cancer	1.69e-05	0.000379	CcSEcCtD
Valrubicin—Haematuria—Doxorubicin—hematologic cancer	1.69e-05	0.000378	CcSEcCtD
Valrubicin—Headache—Vincristine—hematologic cancer	1.68e-05	0.000377	CcSEcCtD
Valrubicin—TOP2A—Azacitidine—Pentostatin—hematologic cancer	1.68e-05	0.0127	CbGdCrCtD
Valrubicin—Nausea—Carmustine—hematologic cancer	1.67e-05	0.000375	CcSEcCtD
Valrubicin—Vomiting—Irinotecan—hematologic cancer	1.66e-05	0.000373	CcSEcCtD
Valrubicin—Vomiting—Mitoxantrone—hematologic cancer	1.66e-05	0.000373	CcSEcCtD
Valrubicin—Nausea—Alitretinoin—hematologic cancer	1.66e-05	0.000371	CcSEcCtD
Valrubicin—TOP2A—Clofarabine—Cladribine—hematologic cancer	1.65e-05	0.0125	CbGdCrCtD
Valrubicin—Rash—Irinotecan—hematologic cancer	1.65e-05	0.00037	CcSEcCtD
Valrubicin—Rash—Mitoxantrone—hematologic cancer	1.65e-05	0.00037	CcSEcCtD
Valrubicin—Dermatitis—Mitoxantrone—hematologic cancer	1.65e-05	0.00037	CcSEcCtD
Valrubicin—Dermatitis—Irinotecan—hematologic cancer	1.65e-05	0.00037	CcSEcCtD
Valrubicin—Headache—Irinotecan—hematologic cancer	1.64e-05	0.000368	CcSEcCtD
Valrubicin—Headache—Mitoxantrone—hematologic cancer	1.64e-05	0.000368	CcSEcCtD
Valrubicin—Nausea—Ifosfamide—hematologic cancer	1.64e-05	0.000367	CcSEcCtD
Valrubicin—TOP2A—Mitotic G1-G1/S phases—MYC—hematologic cancer	1.64e-05	0.00203	CbGpPWpGaD
Valrubicin—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	1.63e-05	0.000366	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Betamethasone—hematologic cancer	1.63e-05	0.000366	CcSEcCtD
Valrubicin—Myalgia—Prednisone—hematologic cancer	1.63e-05	0.000365	CcSEcCtD
Valrubicin—Feeling abnormal—Triamcinolone—hematologic cancer	1.63e-05	0.000365	CcSEcCtD
Valrubicin—Diarrhoea—Cisplatin—hematologic cancer	1.63e-05	0.000365	CcSEcCtD
Valrubicin—Vomiting—Gemcitabine—hematologic cancer	1.62e-05	0.000363	CcSEcCtD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1B—hematologic cancer	1.62e-05	0.00201	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle—HSP90AA1—hematologic cancer	1.61e-05	0.002	CbGpPWpGaD
Valrubicin—Discomfort—Prednisone—hematologic cancer	1.61e-05	0.000361	CcSEcCtD
Valrubicin—Rash—Gemcitabine—hematologic cancer	1.61e-05	0.00036	CcSEcCtD
Valrubicin—Dermatitis—Gemcitabine—hematologic cancer	1.61e-05	0.00036	CcSEcCtD
Valrubicin—Headache—Gemcitabine—hematologic cancer	1.6e-05	0.000358	CcSEcCtD
Valrubicin—Nausea—Vincristine—hematologic cancer	1.6e-05	0.000358	CcSEcCtD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—hematologic cancer	1.59e-05	0.00197	CbGpPWpGaD
Valrubicin—TOP2A—Gemcitabine—Cytarabine—hematologic cancer	1.57e-05	0.0119	CbGdCrCtD
Valrubicin—Oedema peripheral—Doxorubicin—hematologic cancer	1.57e-05	0.000351	CcSEcCtD
Valrubicin—Asthenia—Etoposide—hematologic cancer	1.56e-05	0.00035	CcSEcCtD
Valrubicin—Body temperature increased—Triamcinolone—hematologic cancer	1.56e-05	0.00035	CcSEcCtD
Valrubicin—Nausea—Irinotecan—hematologic cancer	1.55e-05	0.000349	CcSEcCtD
Valrubicin—Nausea—Mitoxantrone—hematologic cancer	1.55e-05	0.000349	CcSEcCtD
Valrubicin—TOP2A—Cell Cycle, Mitotic—CDKN2B—hematologic cancer	1.55e-05	0.00192	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—hematologic cancer	1.55e-05	0.00192	CbGpPWpGaD
Valrubicin—Back pain—Methotrexate—hematologic cancer	1.55e-05	0.000347	CcSEcCtD
Valrubicin—TOP2A—Cell Cycle—CCND2—hematologic cancer	1.54e-05	0.00191	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—JUN—hematologic cancer	1.54e-05	0.00191	CbGpPWpGaD
Valrubicin—Pruritus—Etoposide—hematologic cancer	1.54e-05	0.000345	CcSEcCtD
Valrubicin—TOP2A—Cytarabine—Fludarabine—hematologic cancer	1.53e-05	0.0116	CbGdCrCtD
Valrubicin—Nausea—Gemcitabine—hematologic cancer	1.51e-05	0.00034	CcSEcCtD
Valrubicin—Vomiting—Cisplatin—hematologic cancer	1.51e-05	0.000339	CcSEcCtD
Valrubicin—Rash—Cisplatin—hematologic cancer	1.5e-05	0.000336	CcSEcCtD
Valrubicin—Dermatitis—Cisplatin—hematologic cancer	1.5e-05	0.000336	CcSEcCtD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1A—hematologic cancer	1.5e-05	0.00185	CbGpPWpGaD
Valrubicin—TOP2A—Azacitidine—Clofarabine—hematologic cancer	1.49e-05	0.0113	CbGdCrCtD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—hematologic cancer	1.49e-05	0.00185	CbGpPWpGaD
Valrubicin—Diarrhoea—Etoposide—hematologic cancer	1.49e-05	0.000334	CcSEcCtD
Valrubicin—Ill-defined disorder—Methotrexate—hematologic cancer	1.48e-05	0.000332	CcSEcCtD
Valrubicin—TOP2A—Circadian rythm related genes—JUN—hematologic cancer	1.48e-05	0.00184	CbGpPWpGaD
Valrubicin—Anaemia—Methotrexate—hematologic cancer	1.48e-05	0.000331	CcSEcCtD
Valrubicin—Feeling abnormal—Dexamethasone—hematologic cancer	1.48e-05	0.000331	CcSEcCtD
Valrubicin—Feeling abnormal—Betamethasone—hematologic cancer	1.48e-05	0.000331	CcSEcCtD
Valrubicin—Flatulence—Epirubicin—hematologic cancer	1.47e-05	0.00033	CcSEcCtD
Valrubicin—Gastrointestinal pain—Dexamethasone—hematologic cancer	1.46e-05	0.000329	CcSEcCtD
Valrubicin—Gastrointestinal pain—Betamethasone—hematologic cancer	1.46e-05	0.000329	CcSEcCtD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK8—hematologic cancer	1.46e-05	0.00181	CbGpPWpGaD
Valrubicin—Back pain—Epirubicin—hematologic cancer	1.45e-05	0.000324	CcSEcCtD
Valrubicin—TOP2A—Cytarabine—Gemcitabine—hematologic cancer	1.44e-05	0.0109	CbGdCrCtD
Valrubicin—Malaise—Methotrexate—hematologic cancer	1.44e-05	0.000323	CcSEcCtD
Valrubicin—Dizziness—Etoposide—hematologic cancer	1.44e-05	0.000323	CcSEcCtD
Valrubicin—TOP2A—Circadian rythm related genes—PTEN—hematologic cancer	1.43e-05	0.00178	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—EP300—hematologic cancer	1.42e-05	0.00176	CbGpPWpGaD
Valrubicin—Musculoskeletal discomfort—Prednisone—hematologic cancer	1.42e-05	0.000319	CcSEcCtD
Valrubicin—Dizziness—Prednisolone—hematologic cancer	1.42e-05	0.000318	CcSEcCtD
Valrubicin—Asthenia—Triamcinolone—hematologic cancer	1.42e-05	0.000318	CcSEcCtD
Valrubicin—Body temperature increased—Dexamethasone—hematologic cancer	1.42e-05	0.000318	CcSEcCtD
Valrubicin—Abdominal pain—Dexamethasone—hematologic cancer	1.42e-05	0.000318	CcSEcCtD
Valrubicin—Abdominal pain—Betamethasone—hematologic cancer	1.42e-05	0.000318	CcSEcCtD
Valrubicin—Body temperature increased—Betamethasone—hematologic cancer	1.42e-05	0.000318	CcSEcCtD
Valrubicin—Nausea—Cisplatin—hematologic cancer	1.41e-05	0.000316	CcSEcCtD
Valrubicin—TOP2A—Azacitidine—Nelarabine—hematologic cancer	1.4e-05	0.0106	CbGdCrCtD
Valrubicin—TOP2A—Circadian rythm related genes—MAPK8—hematologic cancer	1.4e-05	0.00174	CbGpPWpGaD
Valrubicin—Pruritus—Triamcinolone—hematologic cancer	1.4e-05	0.000313	CcSEcCtD
Valrubicin—Ill-defined disorder—Epirubicin—hematologic cancer	1.39e-05	0.000311	CcSEcCtD
Valrubicin—TOP2A—Cell Cycle—CDKN2B—hematologic cancer	1.38e-05	0.00172	CbGpPWpGaD
Valrubicin—Vomiting—Etoposide—hematologic cancer	1.38e-05	0.00031	CcSEcCtD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—SRC—hematologic cancer	1.38e-05	0.00172	CbGpPWpGaD
Valrubicin—Anaemia—Epirubicin—hematologic cancer	1.38e-05	0.00031	CcSEcCtD
Valrubicin—Rash—Etoposide—hematologic cancer	1.37e-05	0.000308	CcSEcCtD
Valrubicin—Dermatitis—Etoposide—hematologic cancer	1.37e-05	0.000307	CcSEcCtD
Valrubicin—TOP2A—Circadian rythm related genes—EP300—hematologic cancer	1.37e-05	0.00169	CbGpPWpGaD
Valrubicin—Headache—Etoposide—hematologic cancer	1.36e-05	0.000306	CcSEcCtD
Valrubicin—Flatulence—Doxorubicin—hematologic cancer	1.36e-05	0.000306	CcSEcCtD
Valrubicin—Chest pain—Methotrexate—hematologic cancer	1.36e-05	0.000305	CcSEcCtD
Valrubicin—Myalgia—Methotrexate—hematologic cancer	1.36e-05	0.000305	CcSEcCtD
Valrubicin—Rash—Prednisolone—hematologic cancer	1.35e-05	0.000304	CcSEcCtD
Valrubicin—Dermatitis—Prednisolone—hematologic cancer	1.35e-05	0.000303	CcSEcCtD
Valrubicin—Malaise—Epirubicin—hematologic cancer	1.35e-05	0.000302	CcSEcCtD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—hematologic cancer	1.35e-05	0.00167	CbGpPWpGaD
Valrubicin—Headache—Prednisolone—hematologic cancer	1.34e-05	0.000302	CcSEcCtD
Valrubicin—Discomfort—Methotrexate—hematologic cancer	1.34e-05	0.000301	CcSEcCtD
Valrubicin—TOP2A—Idarubicin—Epirubicin—hematologic cancer	1.34e-05	0.0101	CbGdCrCtD
Valrubicin—TOP2A—Doxorubicin—Epirubicin—hematologic cancer	1.34e-05	0.0101	CbGdCrCtD
Valrubicin—TOP2A—Daunorubicin—Epirubicin—hematologic cancer	1.34e-05	0.0101	CbGdCrCtD
Valrubicin—Back pain—Doxorubicin—hematologic cancer	1.34e-05	0.0003	CcSEcCtD
Valrubicin—TOP2A—Cell Cycle, Mitotic—BIRC5—hematologic cancer	1.34e-05	0.00166	CbGpPWpGaD
Valrubicin—Dizziness—Triamcinolone—hematologic cancer	1.31e-05	0.000293	CcSEcCtD
Valrubicin—Nausea—Etoposide—hematologic cancer	1.29e-05	0.00029	CcSEcCtD
Valrubicin—Feeling abnormal—Prednisone—hematologic cancer	1.29e-05	0.000288	CcSEcCtD
Valrubicin—Asthenia—Betamethasone—hematologic cancer	1.29e-05	0.000288	CcSEcCtD
Valrubicin—Asthenia—Dexamethasone—hematologic cancer	1.29e-05	0.000288	CcSEcCtD
Valrubicin—Ill-defined disorder—Doxorubicin—hematologic cancer	1.28e-05	0.000288	CcSEcCtD
Valrubicin—Anaemia—Doxorubicin—hematologic cancer	1.28e-05	0.000287	CcSEcCtD
Valrubicin—Gastrointestinal pain—Prednisone—hematologic cancer	1.28e-05	0.000286	CcSEcCtD
Valrubicin—Nausea—Prednisolone—hematologic cancer	1.28e-05	0.000286	CcSEcCtD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	1.27e-05	0.00158	CbGpPWpGaD
Valrubicin—Myalgia—Epirubicin—hematologic cancer	1.27e-05	0.000285	CcSEcCtD
Valrubicin—Chest pain—Epirubicin—hematologic cancer	1.27e-05	0.000285	CcSEcCtD
Valrubicin—Pruritus—Betamethasone—hematologic cancer	1.27e-05	0.000284	CcSEcCtD
Valrubicin—Pruritus—Dexamethasone—hematologic cancer	1.27e-05	0.000284	CcSEcCtD
Valrubicin—Discomfort—Epirubicin—hematologic cancer	1.26e-05	0.000282	CcSEcCtD
Valrubicin—Vomiting—Triamcinolone—hematologic cancer	1.26e-05	0.000282	CcSEcCtD
Valrubicin—Malaise—Doxorubicin—hematologic cancer	1.25e-05	0.00028	CcSEcCtD
Valrubicin—Rash—Triamcinolone—hematologic cancer	1.24e-05	0.000279	CcSEcCtD
Valrubicin—Dermatitis—Triamcinolone—hematologic cancer	1.24e-05	0.000279	CcSEcCtD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	1.24e-05	0.00154	CbGpPWpGaD
Valrubicin—TOP2A—Daunorubicin—Doxorubicin—hematologic cancer	1.24e-05	0.00938	CbGdCrCtD
Valrubicin—TOP2A—Epirubicin—Doxorubicin—hematologic cancer	1.24e-05	0.00938	CbGdCrCtD
Valrubicin—TOP2A—Idarubicin—Doxorubicin—hematologic cancer	1.24e-05	0.00938	CbGdCrCtD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	1.24e-05	0.00153	CbGpPWpGaD
Valrubicin—Headache—Triamcinolone—hematologic cancer	1.24e-05	0.000277	CcSEcCtD
Valrubicin—Abdominal pain—Prednisone—hematologic cancer	1.23e-05	0.000277	CcSEcCtD
Valrubicin—Body temperature increased—Prednisone—hematologic cancer	1.23e-05	0.000277	CcSEcCtD
Valrubicin—TOP2A—Cell Cycle, Mitotic—CDK2—hematologic cancer	1.23e-05	0.00152	CbGpPWpGaD
Valrubicin—Diarrhoea—Dexamethasone—hematologic cancer	1.23e-05	0.000275	CcSEcCtD
Valrubicin—Diarrhoea—Betamethasone—hematologic cancer	1.23e-05	0.000275	CcSEcCtD
Valrubicin—TOP2A—Cell Cycle—BIRC5—hematologic cancer	1.2e-05	0.00148	CbGpPWpGaD
Valrubicin—Musculoskeletal discomfort—Methotrexate—hematologic cancer	1.19e-05	0.000266	CcSEcCtD
Valrubicin—Dizziness—Betamethasone—hematologic cancer	1.18e-05	0.000266	CcSEcCtD
Valrubicin—Dizziness—Dexamethasone—hematologic cancer	1.18e-05	0.000266	CcSEcCtD
Valrubicin—Chest pain—Doxorubicin—hematologic cancer	1.18e-05	0.000264	CcSEcCtD
Valrubicin—Myalgia—Doxorubicin—hematologic cancer	1.18e-05	0.000264	CcSEcCtD
Valrubicin—Nausea—Triamcinolone—hematologic cancer	1.17e-05	0.000263	CcSEcCtD
Valrubicin—Discomfort—Doxorubicin—hematologic cancer	1.16e-05	0.000261	CcSEcCtD
Valrubicin—TOP2A—Cell Cycle, Mitotic—CDK4—hematologic cancer	1.16e-05	0.00144	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle—TERT—hematologic cancer	1.16e-05	0.00144	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	1.15e-05	0.00143	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	1.15e-05	0.00142	CbGpPWpGaD
Valrubicin—Vomiting—Betamethasone—hematologic cancer	1.14e-05	0.000255	CcSEcCtD
Valrubicin—Vomiting—Dexamethasone—hematologic cancer	1.14e-05	0.000255	CcSEcCtD
Valrubicin—Rash—Betamethasone—hematologic cancer	1.13e-05	0.000253	CcSEcCtD
Valrubicin—Rash—Dexamethasone—hematologic cancer	1.13e-05	0.000253	CcSEcCtD
Valrubicin—Dermatitis—Betamethasone—hematologic cancer	1.13e-05	0.000253	CcSEcCtD
Valrubicin—Dermatitis—Dexamethasone—hematologic cancer	1.13e-05	0.000253	CcSEcCtD
Valrubicin—Headache—Betamethasone—hematologic cancer	1.12e-05	0.000252	CcSEcCtD
Valrubicin—Headache—Dexamethasone—hematologic cancer	1.12e-05	0.000252	CcSEcCtD
Valrubicin—Asthenia—Prednisone—hematologic cancer	1.12e-05	0.000251	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Epirubicin—hematologic cancer	1.11e-05	0.000249	CcSEcCtD
Valrubicin—Pruritus—Prednisone—hematologic cancer	1.1e-05	0.000248	CcSEcCtD
Valrubicin—TOP2A—Azacitidine—Fludarabine—hematologic cancer	1.1e-05	0.0083	CbGdCrCtD
Valrubicin—TOP2A—Cell Cycle—CDK2—hematologic cancer	1.1e-05	0.00136	CbGpPWpGaD
Valrubicin—Feeling abnormal—Methotrexate—hematologic cancer	1.07e-05	0.000241	CcSEcCtD
Valrubicin—Diarrhoea—Prednisone—hematologic cancer	1.07e-05	0.000239	CcSEcCtD
Valrubicin—Gastrointestinal pain—Methotrexate—hematologic cancer	1.07e-05	0.000239	CcSEcCtD
Valrubicin—Nausea—Dexamethasone—hematologic cancer	1.06e-05	0.000239	CcSEcCtD
Valrubicin—Nausea—Betamethasone—hematologic cancer	1.06e-05	0.000239	CcSEcCtD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	1.05e-05	0.0013	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle—ATM—hematologic cancer	1.04e-05	0.00129	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle—CDK4—hematologic cancer	1.04e-05	0.00128	CbGpPWpGaD
Valrubicin—TOP2A—Azacitidine—Gemcitabine—hematologic cancer	1.04e-05	0.00784	CbGdCrCtD
Valrubicin—TOP2A—Azacitidine—Cytarabine—hematologic cancer	1.04e-05	0.00784	CbGdCrCtD
Valrubicin—Dizziness—Prednisone—hematologic cancer	1.03e-05	0.000231	CcSEcCtD
Valrubicin—Body temperature increased—Methotrexate—hematologic cancer	1.03e-05	0.000231	CcSEcCtD
Valrubicin—Abdominal pain—Methotrexate—hematologic cancer	1.03e-05	0.000231	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.03e-05	0.000231	CcSEcCtD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	1.02e-05	0.00126	CbGpPWpGaD
Valrubicin—TOP2A—Azacitidine—Cladribine—hematologic cancer	1.01e-05	0.00764	CbGdCrCtD
Valrubicin—TOP2A—Cell Cycle, Mitotic—RB1—hematologic cancer	1.01e-05	0.00125	CbGpPWpGaD
Valrubicin—Feeling abnormal—Epirubicin—hematologic cancer	1.01e-05	0.000225	CcSEcCtD
Valrubicin—Gastrointestinal pain—Epirubicin—hematologic cancer	9.98e-06	0.000224	CcSEcCtD
Valrubicin—Vomiting—Prednisone—hematologic cancer	9.92e-06	0.000222	CcSEcCtD
Valrubicin—Rash—Prednisone—hematologic cancer	9.84e-06	0.000221	CcSEcCtD
Valrubicin—Dermatitis—Prednisone—hematologic cancer	9.83e-06	0.00022	CcSEcCtD
Valrubicin—TOP2A—Circadian rythm related genes—TP53—hematologic cancer	9.77e-06	0.00121	CbGpPWpGaD
Valrubicin—Headache—Prednisone—hematologic cancer	9.77e-06	0.000219	CcSEcCtD
Valrubicin—Body temperature increased—Epirubicin—hematologic cancer	9.64e-06	0.000216	CcSEcCtD
Valrubicin—Abdominal pain—Epirubicin—hematologic cancer	9.64e-06	0.000216	CcSEcCtD
Valrubicin—Asthenia—Methotrexate—hematologic cancer	9.35e-06	0.00021	CcSEcCtD
Valrubicin—Feeling abnormal—Doxorubicin—hematologic cancer	9.3e-06	0.000209	CcSEcCtD
Valrubicin—Nausea—Prednisone—hematologic cancer	9.27e-06	0.000208	CcSEcCtD
Valrubicin—Gastrointestinal pain—Doxorubicin—hematologic cancer	9.23e-06	0.000207	CcSEcCtD
Valrubicin—Pruritus—Methotrexate—hematologic cancer	9.22e-06	0.000207	CcSEcCtD
Valrubicin—TOP2A—Cell Cycle—RB1—hematologic cancer	9.01e-06	0.00112	CbGpPWpGaD
Valrubicin—TOP2A—Circadian rythm related genes—IL6—hematologic cancer	8.95e-06	0.00111	CbGpPWpGaD
Valrubicin—Abdominal pain—Doxorubicin—hematologic cancer	8.92e-06	0.0002	CcSEcCtD
Valrubicin—Body temperature increased—Doxorubicin—hematologic cancer	8.92e-06	0.0002	CcSEcCtD
Valrubicin—Diarrhoea—Methotrexate—hematologic cancer	8.92e-06	0.0002	CcSEcCtD
Valrubicin—TOP2A—Cell Cycle, Mitotic—CDKN2A—hematologic cancer	8.86e-06	0.0011	CbGpPWpGaD
Valrubicin—Asthenia—Epirubicin—hematologic cancer	8.75e-06	0.000196	CcSEcCtD
Valrubicin—Pruritus—Epirubicin—hematologic cancer	8.63e-06	0.000194	CcSEcCtD
Valrubicin—Dizziness—Methotrexate—hematologic cancer	8.62e-06	0.000193	CcSEcCtD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	8.6e-06	0.00107	CbGpPWpGaD
Valrubicin—Diarrhoea—Epirubicin—hematologic cancer	8.35e-06	0.000187	CcSEcCtD
Valrubicin—Vomiting—Methotrexate—hematologic cancer	8.29e-06	0.000186	CcSEcCtD
Valrubicin—Rash—Methotrexate—hematologic cancer	8.22e-06	0.000184	CcSEcCtD
Valrubicin—Dermatitis—Methotrexate—hematologic cancer	8.21e-06	0.000184	CcSEcCtD
Valrubicin—Headache—Methotrexate—hematologic cancer	8.17e-06	0.000183	CcSEcCtD
Valrubicin—Asthenia—Doxorubicin—hematologic cancer	8.1e-06	0.000182	CcSEcCtD
Valrubicin—Dizziness—Epirubicin—hematologic cancer	8.07e-06	0.000181	CcSEcCtD
Valrubicin—Pruritus—Doxorubicin—hematologic cancer	7.99e-06	0.000179	CcSEcCtD
Valrubicin—TOP2A—Cell Cycle—CDKN2A—hematologic cancer	7.92e-06	0.000982	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle, Mitotic—CDKN1B—hematologic cancer	7.84e-06	0.000972	CbGpPWpGaD
Valrubicin—Vomiting—Epirubicin—hematologic cancer	7.76e-06	0.000174	CcSEcCtD
Valrubicin—Nausea—Methotrexate—hematologic cancer	7.74e-06	0.000174	CcSEcCtD
Valrubicin—Diarrhoea—Doxorubicin—hematologic cancer	7.72e-06	0.000173	CcSEcCtD
Valrubicin—Rash—Epirubicin—hematologic cancer	7.69e-06	0.000173	CcSEcCtD
Valrubicin—Dermatitis—Epirubicin—hematologic cancer	7.69e-06	0.000172	CcSEcCtD
Valrubicin—TOP2A—Cell Cycle—MDM2—hematologic cancer	7.68e-06	0.000952	CbGpPWpGaD
Valrubicin—Headache—Epirubicin—hematologic cancer	7.64e-06	0.000171	CcSEcCtD
Valrubicin—TOP2A—Cell Cycle, Mitotic—CCND1—hematologic cancer	7.48e-06	0.000928	CbGpPWpGaD
Valrubicin—Dizziness—Doxorubicin—hematologic cancer	7.47e-06	0.000167	CcSEcCtD
Valrubicin—Nausea—Epirubicin—hematologic cancer	7.25e-06	0.000163	CcSEcCtD
Valrubicin—TOP2A—Cell Cycle, Mitotic—CDKN1A—hematologic cancer	7.24e-06	0.000897	CbGpPWpGaD
Valrubicin—Vomiting—Doxorubicin—hematologic cancer	7.18e-06	0.000161	CcSEcCtD
Valrubicin—Rash—Doxorubicin—hematologic cancer	7.12e-06	0.00016	CcSEcCtD
Valrubicin—Dermatitis—Doxorubicin—hematologic cancer	7.11e-06	0.000159	CcSEcCtD
Valrubicin—Headache—Doxorubicin—hematologic cancer	7.07e-06	0.000159	CcSEcCtD
Valrubicin—TOP2A—Cell Cycle—CDKN1B—hematologic cancer	7.01e-06	0.000869	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle, Mitotic—EP300—hematologic cancer	6.89e-06	0.000854	CbGpPWpGaD
Valrubicin—Nausea—Doxorubicin—hematologic cancer	6.71e-06	0.00015	CcSEcCtD
Valrubicin—TOP2A—Cell Cycle—CCND1—hematologic cancer	6.69e-06	0.000829	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle—CDKN1A—hematologic cancer	6.47e-06	0.000802	CbGpPWpGaD
Valrubicin—TOP2A—Methyltestosterone—Prednisone—hematologic cancer	6.18e-06	0.00468	CbGdCrCtD
Valrubicin—TOP2A—Cell Cycle, Mitotic—MAPK3—hematologic cancer	6.17e-06	0.000765	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle—EP300—hematologic cancer	6.16e-06	0.000763	CbGpPWpGaD
Valrubicin—TOP2A—Methyltestosterone—Prednisolone—hematologic cancer	6.04e-06	0.00457	CbGdCrCtD
Valrubicin—TOP2A—Cell Cycle, Mitotic—MYC—hematologic cancer	6e-06	0.000744	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle—MAPK3—hematologic cancer	5.52e-06	0.000684	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle—MYC—hematologic cancer	5.37e-06	0.000665	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle—TP53—hematologic cancer	4.41e-06	0.000546	CbGpPWpGaD
